And recent studies have also shown that Musashi-2 is involved in metabolism related pathways to regulate cancer development and progression, including the reprogramming of branched-chain amino acids metabolism in myeloid leukaemia (44) and the regulation of glycolipid metabolism in Glioma (45). Here, MSI2 is linked to glioma.